星空体育官方入口网站网址大全-登录入口官网

#糖尿病性黄斑水肿#

23篇内容 | 1300人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2214219, encodeId=b2ed2214219b8, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=阿柏西普8mg治疗糖尿病性黄斑水肿中国III期临床研究启动, objectType=article, longId=827287, objectId=0db382e28762, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240710/1720580262876_92910.jpg, objectUrl=/article/show_article.do?id=0db382e28762, replyNumber=0, likeNumber=18, createdTime=2024-07-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0db382e28762, moduleTitle=阿柏西普8mg治疗糖尿病性黄斑水肿中国III期临床研究启动, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0db382e28762)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188656, encodeId=6794218865609, content=<a href='/topic/show?id=cbad9e850a6' target=_blank style='color:#2F92EE;'>#阿柏西普#</a> <a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a> <a href='/topic/show?id=9ffc6023393' target=_blank style='color:#2F92EE;'>#曲安奈德#</a>, objectTitle=Int J Ophthalmol：阿柏西普联合曲安奈德对糖尿病性黄斑水肿患者房水生长因子和炎症介质的影响, objectType=article, longId=814173, objectId=34c98141e382, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/267914-eye.jpg, objectUrl=/article/show_article.do?id=34c98141e382, replyNumber=0, likeNumber=0, createdTime=2024-02-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=34c98141e382, moduleTitle=Int J Ophthalmol：阿柏西普联合曲安奈德对糖尿病性黄斑水肿患者房水生长因子和炎症介质的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=34c98141e382)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1401436, encodeId=ead8140143613, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=罗氏 (Roche) 的双特异性Vabysmo获得FDA批准用于湿性AMD、糖尿病性黄斑水肿, objectType=article, longId=295101, objectId=9181295101bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9181295101bf, replyNumber=0, likeNumber=61, createdTime=2022-02-05, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9181295101bf, moduleTitle=罗氏 (Roche) 的双特异性Vabysmo获得FDA批准用于湿性AMD、糖尿病性黄斑水肿, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9181295101bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401435, encodeId=da581401435f0, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=Lancet：双特异性抗体faricimab在湿性或新生血管性年龄相关性黄斑变性（AMD）和糖尿病性黄斑水肿（DME）1年的随访结果, objectType=article, longId=294903, objectId=5c2c29490389, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c2c29490389, replyNumber=0, likeNumber=49, createdTime=2022-01-31, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c2c29490389, moduleTitle=Lancet：双特异性抗体faricimab在湿性或新生血管性年龄相关性黄斑变性（AMD）和糖尿病性黄斑水肿（DME）1年的随访结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5c2c29490389)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401434, encodeId=fca51401434cc, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色, objectType=article, longId=207129, objectId=d13920e12909, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d13920e12909, replyNumber=0, likeNumber=50, createdTime=2021-02-16, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d13920e12909, moduleTitle=长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d13920e12909)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401433, encodeId=c0451401433e9, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=罗氏的Faricimab在糖尿病性黄斑水肿研究中大获成功, objectType=article, longId=205045, objectId=31af20504527, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31af20504527, replyNumber=0, likeNumber=59, createdTime=2021-01-01, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31af20504527, moduleTitle=罗氏的Faricimab在糖尿病性黄斑水肿研究中大获成功, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=31af20504527)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401432, encodeId=6b891401432b0, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=全新糖尿病性黄斑水肿（DME）筛查模型，简单高效助力大规模早筛, objectType=article, longId=204074, objectId=deee2040e43f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deee2040e43f, replyNumber=0, likeNumber=54, createdTime=2020-12-04, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deee2040e43f, moduleTitle=全新糖尿病性黄斑水肿（DME）筛查模型，简单高效助力大规模早筛, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=deee2040e43f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401431, encodeId=4a201401431d7, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=全球不依赖眼底成像的糖尿病性黄斑水肿预测模型重磅发布，提升DME筛查效率，助力糖尿病综合管理, objectType=article, longId=204068, objectId=b2a120406857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2a120406857, replyNumber=0, likeNumber=58, createdTime=2020-12-04, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2a120406857, moduleTitle=全球不依赖眼底成像的糖尿病性黄斑水肿预测模型重磅发布，提升DME筛查效率，助力糖尿病综合管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b2a120406857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401430, encodeId=0178140143039, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果, objectType=article, longId=187876, objectId=f10618e87660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f10618e87660, replyNumber=0, likeNumber=0, createdTime=2020-02-13, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f10618e87660, moduleTitle=KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f10618e87660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401429, encodeId=002f140142928, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=DIABETOLOGIA：抗富马酸酶抗体促进糖尿病性黄斑水肿中感光细胞内外节段的脱落, objectType=article, longId=163580, objectId=c57516358096, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c57516358096, replyNumber=0, likeNumber=48, createdTime=2019-04-05, rootId=0, userName=d830373, userId=f5ec2326645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c57516358096, moduleTitle=DIABETOLOGIA：抗富马酸酶抗体促进糖尿病性黄斑水肿中感光细胞内外节段的脱落, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c57516358096)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401428, encodeId=3da91401428b1, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=PLoS One：糖尿病性黄斑水肿患者房水中的细胞因子水平对抗VEGF治疗, objectType=article, longId=149260, objectId=e98c1492604b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e98c1492604b, replyNumber=0, likeNumber=45, createdTime=2018-09-22, rootId=0, userName=d830373, userId=f5ec2326645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e98c1492604b, moduleTitle=PLoS One：糖尿病性黄斑水肿患者房水中的细胞因子水平对抗VEGF治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e98c1492604b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401427, encodeId=a4a2140142e02, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=Ophthalmologica：地塞米松玻璃体内注射治疗糖尿病性黄斑水肿患者的临床决策, objectType=article, longId=134586, objectId=82cb1345863b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82cb1345863b, replyNumber=0, likeNumber=54, createdTime=2018-04-10, rootId=0, userName=d830373, userId=f5ec2326645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82cb1345863b, moduleTitle=Ophthalmologica：地塞米松玻璃体内注射治疗糖尿病性黄斑水肿患者的临床决策, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=82cb1345863b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401426, encodeId=8ddc1401426ad, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=Am J Med Sci:中国人中骨质代谢标志物与糖尿病视网膜病变和糖尿病性黄斑水肿之间的相关性研究！, objectType=article, longId=120647, objectId=394612064e37, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=394612064e37, replyNumber=0, likeNumber=51, createdTime=2017-11-20, rootId=0, userName=d830373, userId=f5ec2326645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=394612064e37, moduleTitle=Am J Med Sci:中国人中骨质代谢标志物与糖尿病视网膜病变和糖尿病性黄斑水肿之间的相关性研究！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=394612064e37)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401425, encodeId=33741401425d8, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=BMC Ophthalmol：比较康柏西普和雷尼珠单抗治疗糖尿病性黄斑水肿12个月后的治疗效果！, objectType=article, longId=111160, objectId=6155111160b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6155111160b8, replyNumber=0, likeNumber=52, createdTime=2017-08-30, rootId=0, userName=d830373, userId=f5ec2326645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6155111160b8, moduleTitle=BMC Ophthalmol：比较康柏西普和雷尼珠单抗治疗糖尿病性黄斑水肿12个月后的治疗效果！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6155111160b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401424, encodeId=94c614014243b, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=Ophthalmologica.：兰尼单抗对经激光治疗后的糖尿病性黄斑水肿（DME）具有良好疗效！, objectType=article, longId=106075, objectId=04641060e587, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04641060e587, replyNumber=0, likeNumber=76, createdTime=2017-07-22, rootId=0, userName=d830373, userId=f5ec2326645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04641060e587, moduleTitle=Ophthalmologica.：兰尼单抗对经激光治疗后的糖尿病性黄斑水肿（DME）具有良好疗效！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=04641060e587)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401423, encodeId=0a64140142339, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=2015 NICE技术评估指南：阿柏西普治疗糖尿病性黄斑水肿（TA346）, objectType=article, longId=83778, objectId=4dcc83e787c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dcc83e787c, replyNumber=0, likeNumber=48, createdTime=2016-12-09, rootId=0, userName=d830373, userId=f5ec2326645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dcc83e787c, moduleTitle=2015 NICE技术评估指南：阿柏西普治疗糖尿病性黄斑水肿（TA346）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4dcc83e787c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401422, encodeId=bab9140142293, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=【盘点】有关糖尿病性黄斑水肿研究进展汇总, objectType=article, longId=81041, objectId=e9e98104114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9e98104114, replyNumber=0, likeNumber=61, createdTime=2016-10-27, rootId=0, userName=d830373, userId=f5ec2326645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9e98104114, moduleTitle=【盘点】有关糖尿病性黄斑水肿研究进展汇总, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e9e98104114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401421, encodeId=8ec71401421b2, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=2015NICE技术评估指南：玻璃体腔内注射地塞米松治疗糖尿病性黄斑水肿（TA349）发布, objectType=article, longId=81028, objectId=081881028be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=081881028be, replyNumber=0, likeNumber=57, createdTime=2016-10-27, rootId=0, userName=d830373, userId=f5ec2326645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=081881028be, moduleTitle=2015NICE技术评估指南：玻璃体腔内注射地塞米松治疗糖尿病性黄斑水肿（TA349）发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=081881028be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401420, encodeId=04f4140142017, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=JAMA Ophthalmol：糖尿病性黄斑水肿选择什么药更划算？, objectType=article, longId=70510, objectId=02d9e051080, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02d9e051080, replyNumber=0, likeNumber=60, createdTime=2016-06-13, rootId=0, userName=d830373, userId=f5ec2326645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02d9e051080, moduleTitle=JAMA Ophthalmol：糖尿病性黄斑水肿选择什么药更划算？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=02d9e051080)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401419, encodeId=a82e1401419f9, content=<a href='/topic/show?id=a609e6715c6' target=_blank style='color:#2F92EE;'>#糖尿病性黄斑水肿#</a>, objectTitle=BMJ研究新闻：对于中重度糖尿病性黄斑水肿患者，阿柏西普的治疗效果优于贝伐单抗及雷珠单抗, objectType=article, longId=63953, objectId=41d26395382, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41d26395382, replyNumber=0, likeNumber=53, createdTime=2016-03-02, rootId=0, userName=d830373, userId=f5ec2326645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41d26395382, moduleTitle=BMJ研究新闻：对于中重度糖尿病性黄斑水肿患者，阿柏西普的治疗效果优于贝伐单抗及雷珠单抗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=41d26395382)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

糖尿病性黄斑水肿

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

阿柏西普8mg治疗糖尿病性黄斑水肿中国III期临床研究启动

2024-07-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#阿柏西普# #糖尿病性黄斑水肿# #曲安奈德#

Int J Ophthalmol：阿柏西普联合曲安奈德对糖尿病性黄斑水肿患者房水生长因子和炎症介质的影响

2024-02-22发表于上海

zhouqu_8 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

罗氏 (Roche) 的双特异性Vabysmo获得FDA批准用于湿性AMD、糖尿病性黄斑水肿

2022-02-05

zhouqu_8 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

Lancet：双特异性抗体faricimab在湿性或新生血管性年龄相关性黄斑变性（AMD）和糖尿病性黄斑水肿（DME）1年的随访结果

2022-01-31

zhouqu_8 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

长效双特异性抗体faricimab用于特定黄斑变性和糖尿病性黄斑水肿，4个月注射一次，效果出色

2021-02-16

zhouqu_8 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

罗氏的Faricimab在糖尿病性黄斑水肿研究中大获成功

2021-01-01

zhouqu_8 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

全新糖尿病性黄斑水肿（DME）筛查模型，简单高效助力大规模早筛

2020-12-04

zhouqu_8 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

全球不依赖眼底成像的糖尿病性黄斑水肿预测模型重磅发布，提升DME筛查效率，助力糖尿病综合管理

2020-12-04

zhouqu_8 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果

2020-02-13

d830373 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

DIABETOLOGIA：抗富马酸酶抗体促进糖尿病性黄斑水肿中感光细胞内外节段的脱落

2019-04-05

d830373 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

PLoS One：糖尿病性黄斑水肿患者房水中的细胞因子水平对抗VEGF治疗

2018-09-22

d830373 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

Ophthalmologica：地塞米松玻璃体内注射治疗糖尿病性黄斑水肿患者的临床决策

2018-04-10

d830373 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

Am J Med Sci:中国人中骨质代谢标志物与糖尿病视网膜病变和糖尿病性黄斑水肿之间的相关性研究！

2017-11-20

d830373 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

BMC Ophthalmol：比较康柏西普和雷尼珠单抗治疗糖尿病性黄斑水肿12个月后的治疗效果！

2017-08-30

d830373 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

Ophthalmologica.：兰尼单抗对经激光治疗后的糖尿病性黄斑水肿（DME）具有良好疗效！

2017-07-22

d830373 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

2015 NICE技术评估指南：阿柏西普治疗糖尿病性黄斑水肿（TA346）

2016-12-09

d830373 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

【盘点】有关糖尿病性黄斑水肿研究进展汇总

2016-10-27

d830373 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

2015NICE技术评估指南：玻璃体腔内注射地塞米松治疗糖尿病性黄斑水肿（TA349）发布

2016-10-27

d830373 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

JAMA Ophthalmol：糖尿病性黄斑水肿选择什么药更划算？

2016-06-13

d830373 (审核中...)

前往app查看评论内容

#糖尿病性黄斑水肿#

BMJ研究新闻：对于中重度糖尿病性黄斑水肿患者，阿柏西普的治疗效果优于贝伐单抗及雷珠单抗

2016-03-02

科室
- - 订阅+
  - 更多科室
工具
服务